These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1319983)
21. Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing. Chung YT; Chen CL; Wu CC; Chan SA; Chi CW; Liu TY Toxicol Lett; 2008 Dec; 183(1-3):21-7. PubMed ID: 18938230 [TBL] [Abstract][Full Text] [Related]
22. Evidence for the hormone dependency of hepatic hyperplastic nodules: inhibition of malignant transformation after exogenous 17 beta-estradiol and tamoxifen. Mishkin SY; Farber E; Ho RK; Mulay S; Mishkin S Hepatology; 1983; 3(3):308-16. PubMed ID: 6840677 [TBL] [Abstract][Full Text] [Related]
23. Inefficient repair of tamoxifen-DNA adducts in rats and mice. Kim SY; Suzuki N; Laxmi YR; Shibutani S Drug Metab Dispos; 2006 Feb; 34(2):311-7. PubMed ID: 16299164 [TBL] [Abstract][Full Text] [Related]
24. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days. Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927 [TBL] [Abstract][Full Text] [Related]
25. 32P analysis of DNA adducts in tissues of benzene-treated rats. Reddy MV; Blackburn GR; Schreiner CA; Mehlman MA; Mackerer CR Environ Health Perspect; 1989 Jul; 82():253-7. PubMed ID: 2792046 [TBL] [Abstract][Full Text] [Related]
26. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. Tryndyak VP; Muskhelishvili L; Kovalchuk O; Rodriguez-Juarez R; Montgomery B; Churchwell MI; Ross SA; Beland FA; Pogribny IP Carcinogenesis; 2006 Aug; 27(8):1713-20. PubMed ID: 16632870 [TBL] [Abstract][Full Text] [Related]
27. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling. Stiborová M; Breuer A; Aimová D; Stiborová-Rupertová M; Wiessler M; Frei E Int J Cancer; 2003 Dec; 107(6):885-90. PubMed ID: 14601046 [TBL] [Abstract][Full Text] [Related]
28. Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats. Phillips DH; Hewer A; White IN; Farmer PB Carcinogenesis; 1994 May; 15(5):793-5. PubMed ID: 8200077 [TBL] [Abstract][Full Text] [Related]
29. Changes in estrogen receptor, DNA ploidy, and estrogen metabolism in rat hepatocytes during a two-stage model for hepatocarcinogenesis using 17 alpha-ethinylestradiol as the promoting agent. Vickers AE; Nelson K; McCoy Z; Lucier GW Cancer Res; 1989 Dec; 49(23):6512-20. PubMed ID: 2573415 [TBL] [Abstract][Full Text] [Related]
30. Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver. Werner S; Topinka J; Wolff T; Schwarz LR Carcinogenesis; 1995 Oct; 16(10):2369-72. PubMed ID: 7586137 [TBL] [Abstract][Full Text] [Related]
31. Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver. Hallstrom IP; Liao DZ; Assefaw-Redda Y; Ohlson LC; Sahlin L; Eneroth P; Eriksson LC; Gustafsson JA; Blanck A Hepatology; 1996 Oct; 24(4):849-54. PubMed ID: 8855187 [TBL] [Abstract][Full Text] [Related]
32. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction. Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433 [TBL] [Abstract][Full Text] [Related]
33. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo. Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775 [TBL] [Abstract][Full Text] [Related]
34. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene. Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033 [TBL] [Abstract][Full Text] [Related]
35. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling. Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009 [TBL] [Abstract][Full Text] [Related]
36. Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adduct formation in female mouse tissues. Pfohl-Leszkowicz A; Chekir-Ghedira L; Bacha H Carcinogenesis; 1995 Oct; 16(10):2315-20. PubMed ID: 7586128 [TBL] [Abstract][Full Text] [Related]
37. [Establishment of an estrogen receptor positive 3'-methyl-4-dimethylaminoazobenzene induced hepatoma cell line of rat and investigation of hormonal therapy]. Kameda H Hokkaido Igaku Zasshi; 1996 Nov; 71(6):711-26. PubMed ID: 8996840 [TBL] [Abstract][Full Text] [Related]
38. Role of estrogens as promoters of hepatic neoplasia. Wanless IR; Medline A Lab Invest; 1982 Mar; 46(3):313-20. PubMed ID: 6278220 [TBL] [Abstract][Full Text] [Related]
39. Monitoring carcinogen actions on DNA by 32P-postlabeling. Randerath K; Randerath E Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by tamoxifen without decrease in DNA adduct levels. Liehr JG; Sirbasku DA; Jurka E; Randerath K; Randerath E Cancer Res; 1988 Feb; 48(4):779-83. PubMed ID: 3338075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]